Poly(ADP-ribose) Polymerase 1 (PARP-1) Binds to 8-Oxoguanine-DNA Glycosylase (OGG1)

被引:95
|
作者
Noren Hooten, Nicole [1 ]
Kompaniez, Kari [1 ]
Barnes, Janice [1 ]
Lohani, Althaf [1 ]
Evans, Michele K. [1 ,2 ]
机构
[1] NIA, Lab Mol Biol & Immunol, NIH, 251 Bayview Bld, Baltimore, MD 21224 USA
[2] NIA, Clin Res Branch, NIH, Baltimore, MD 21224 USA
基金
美国国家卫生研究院;
关键词
BASE-EXCISION-REPAIR; DNA-DAMAGE; GENETIC POLYMORPHISMS; OXIDATIVE DAMAGE; HUMAN HOMOLOG; CANCER; CLONING; CELLS; HOGG1; 8-HYDROXYGUANINE;
D O I
10.1074/jbc.M111.255869
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human 8-oxoguanine-DNA glycosylase (OGG1) plays a major role in the base excision repair pathway by removing 8-oxoguanine base lesions generated by reactive oxygen species. Here we report a novel interaction between OGG1 and Poly( ADP-ribose) polymerase 1 (PARP-1), a DNA-damage sensor protein involved in DNA repair and many other cellular processes. We found that OGG1 binds directly to PARP-1 through the N-terminal region of OGG1, and this interaction is enhanced by oxidative stress. Furthermore, OGG1 binds to PARP-1 through its BRCA1 C-terminal (BRCT) domain. OGG1 stimulated the poly(ADP-ribosyl)ation activity of PARP-1, whereas decreased poly(ADP-ribose) levels were observed in OGG1(-/-) cells compared with wild-type cells in response to DNA damage. Importantly, activated PARP-1 inhibits OGG1. Although the OGG1 polymorphic variant proteins R229Q and S326C bind to PARP-1, these proteins were defective in activating PARP-1. Furthermore, OGG1(-/-) cells were more sensitive to PARP inhibitors alone or in combination with a DNA-damaging agent. These findings indicate that OGG1 binding to PARP-1 plays a functional role in the repair of oxidative DNA damage.
引用
收藏
页码:44679 / 44690
页数:12
相关论文
共 50 条
  • [41] Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors
    Navriti Chadha
    Ameteshar Singh Jaggi
    Om Silakari
    Molecular Diversity, 2017, 21 : 655 - 660
  • [42] Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases
    S Gobeil
    C C Boucher
    D Nadeau
    G G Poirier
    Cell Death & Differentiation, 2001, 8 : 588 - 594
  • [43] Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases
    Gobeil, S
    Boucher, CC
    Nadeau, D
    Poirier, GG
    CELL DEATH AND DIFFERENTIATION, 2001, 8 (06): : 588 - 594
  • [44] Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors
    Chadha, Navriti
    Jaggi, Ameteshar Singh
    Silakari, Om
    MOLECULAR DIVERSITY, 2017, 21 (03) : 655 - 660
  • [45] Quantitative correlation between cellular proliferation and nuclear poly (ADP-ribose) polymerase (PARP-1)
    Kun, E
    Kirsten, E
    Bauer, PI
    Ordahl, CP
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2006, 17 (02) : 293 - 300
  • [46] Poly(ADP-ribose)polymerase-1 (PARP-1) expression and activity in primary human lung cells
    Ahmad, MH
    Torky, A
    Glahn, F
    Raemisch, A
    Foth, H
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 113 - 113
  • [47] Synthesis and Evaluation of a Radioiodinated Tracer with Specificity for Poly(ADP-ribose) Polymerase-1 (PARP-1) in Vivo
    Zmuda, Filip
    Malviya, Gaurav
    Blair, Adele
    Boyd, Marie
    Chalmers, Anthony J.
    Sutherland, Andrew
    Pimlott, Sally L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (21) : 8683 - 8693
  • [48] Poly (ADP-ribose) polymerase-1 (PARP-1) in Chinese patients with Graves' disease and Graves' ophthalmopathy
    Wu, Tong
    Tang, Dong-run
    Zhao, Liang
    Sun, Feng-yuan
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 96 (06) : 556 - 561
  • [49] The role of poly(ADP-ribose) polymerase-1 (PARP-1) in the cellular response to Topoisomerase I poisons
    Smith, L
    Willmore, E
    Hostomsky, Z
    Webber, SE
    Austin, CA
    Curtin, NJ
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S69 - S69
  • [50] Inhibition of poly (ADP-ribose) Polymerase-1 (PARP-1) improves endothelial function in pulmonary hypertension
    Shafiq, Mohammad
    Lone, Zahid Rasool
    Abdulkareem, Adam Olaitan
    Kaur, Gurpreet
    Navya, Sai
    Singh, Himalaya
    Jagavelu, Kumaravelu
    Hanif, Kashif
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80